Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03512223 · ClinicalTrials.gov registry record · Early Phase 1
Intravenous and Perineural Dexamethasone for Brachial Plexus Block in Hand Surgery
A Early Phase 1 study, sponsored by Ohio State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 108
- Enrollment target
NCT03512223: Completed Early Phase 1 study, sponsored by Ohio State University.
NCT03512223 is a Early Phase 1 study that has completed, run by Ohio State University. The registered enrollment target is 108 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (104% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03512223, a Early Phase 1 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 108 participants
- Enrollment target
Study Summary
This study aims to evaluate the if the administration of dexamethasone both around the nerve and in the vein (perineural and intravenous (IV)) will prolong the duration of pain relief from ropivacaine when compared with ropivacaine local block alone or when administered along with IV dexamethasone in patients undergoing hand surgery.
Primary Outcome
• The duration of anesthetic blockade measured by the time from performing the perineural block to the first reported pain at the surgical site between groups
Interventions
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2018-10-23 |
| Est. Completion | 2024-10-20 |
| Phase | Early Phase 1 |
What the finished NCT03512223 record still lists
NCT03512223 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (104% higher).
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.
NCT03512223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03512223 about?
NCT03512223 is a clinical study titled "Intravenous and Perineural Dexamethasone for Brachial Plexus Block in Hand Surgery". This study aims to evaluate the if the administration of dexamethasone both around the nerve and in the vein (perineural and intravenous (IV)) will prolong the duration of pain relief from ropivacaine when compared with ropivacaine local block alone or when administered along with IV dexamethasone i...
What is the current status of trial NCT03512223?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 108 participants. The study started on 2018-10-23. Estimated completion is 2024-10-20.
What interventions are being tested in trial NCT03512223?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03512223?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03512223's enrollment target sits among peer trials
108 170th of 2000 higher than 1,828 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI